Neurometabolic and Functional Changes of Default-mode Network Relate to Clinical Recovery in First-episode Psychosis Patients: A Longitudinal H-MRS and FMRI Study

Overview

Journal Neuroimage Clin

Publisher Elsevier

Specialties Neurology
Radiology

Date 2022 Mar 3

PMID 35240468

Authors

Wenli Li

JiaLe Xu

Qiong Xiang

Kaiming Zhuo

Yaoyu Zhang

Dengtang Liu

Yao Li

Affiliations

Soon will be listed here.

Abstract

Background: Antipsychotic treatment has improved the disrupted functional connectivity (FC) and neurometabolites levels of the default mode network (DMN) in schizophrenia patients, but a direct relationship between FC change, neurometabolic level alteration, and symptom improvement has not been built. This study examined the association between the alterations in DMN FC, the changes of neurometabolites levels in the medial prefrontal cortex (MPFC), and the improvementsinpsychopathology in a longitudinal study of drug-naïve first-episode psychosis (FEP) patients.

Methods: Thirty-two drug-naïve FEP patients and 30 matched healthy controls underwent repeated assessments with the Positive and Negative Syndrome Scale (PANSS) and 3T proton magnetic resonance spectroscopy as well as resting-state functional magnetic resonance imaging. The levels of γ-aminobutyric acid, glutamate, N-acetyl-aspartate in MPFC, and the FC of DMN were measured. After 8-week antipsychotic treatment, 24 patients were re-examined.

Results: After treatment, the changes in γ-aminobutyric acid were correlated with the alterations of FC between the MPFC and DMN, while the changes in N-acetyl-aspartate were associated with the alterations of FC between the posterior cingulate cortex/precuneus and DMN. The FC changes of both regions were correlated with patients PANSS positive score reductions. The structural equation modeling analyses revealed that the changes of DMN FC mediated the relationship between the changes of neurometabolites and the symptom improvements of the patients.

Conclusions: The derived neurometabolic-functional changes underlying the clinical recovery provide insights into the prognosis of FEP patients. It is noteworthy that this is an exploratory study, and future work with larger sample size is needed to validate our findings.

Citing Articles

Network biomarkers in recovered psychosis patients who discontinued antipsychotics.

Odkhuu S, Kim W, Tsogt U, Shen J, Cheraghi S, Li L Mol Psychiatry. 2023; 28(9):3717-3726.

PMID: 37773447 PMC: 10730417. DOI: 10.1038/s41380-023-02279-6.

Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.

Yang Y, Smucny J, Zhang H, Maddock R Neuroimage Clin. 2023; 39:103461.

PMID: 37406595 PMC: 10509531. DOI: 10.1016/j.nicl.2023.103461.

Clinical anatomy of the precuneus and pathogenesis of the schizophrenia.

Messina A, Cucci G, Crescimanno C, Signorelli M Anat Sci Int. 2023; 98(4):473-481.

PMID: 37340095 DOI: 10.1007/s12565-023-00730-w.

Glutamatergic dysfunction in Schizophrenia.

Kruse A, Bustillo J Transl Psychiatry. 2022; 12(1):500.

PMID: 36463316 PMC: 9719533. DOI: 10.1038/s41398-022-02253-w.

Abnormal network homogeneity of default-mode network and its relationships with clinical symptoms in antipsychotic-naïve first-diagnosis schizophrenia.

Kong M, Chen T, Gao S, Ni S, Ming Y, Chai X Front Neurosci. 2022; 16:921547.

PMID: 35968384 PMC: 9369006. DOI: 10.3389/fnins.2022.921547.

References

McCutcheon R, Marques T, Howes O . Schizophrenia-An Overview. JAMA Psychiatry. 2019; 77(2):201-210. DOI: 10.1001/jamapsychiatry.2019.3360. View

Dang L, ONeil J, Jagust W . Dopamine supports coupling of attention-related networks. J Neurosci. 2012; 32(28):9582-7. PMC: 3410707. DOI: 10.1523/JNEUROSCI.0909-12.2012. View

Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57. View

Cen H, Xu J, Yang Z, Mei L, Chen T, Zhuo K . Neurochemical and brain functional changes in the ventromedial prefrontal cortex of first-episode psychosis patients: A combined functional magnetic resonance imaging-proton magnetic resonance spectroscopy study. Aust N Z J Psychiatry. 2020; 54(5):519-527. DOI: 10.1177/0004867419898520. View

Supekar K, Cai W, Krishnadas R, Palaniyappan L, Menon V . Dysregulated Brain Dynamics in a Triple-Network Saliency Model of Schizophrenia and Its Relation to Psychosis. Biol Psychiatry. 2018; 85(1):60-69. DOI: 10.1016/j.biopsych.2018.07.020. View

Sambataro F, Blasi G, Fazio L, Caforio G, Taurisano P, Romano R . Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia. Neuropsychopharmacology. 2009; 35(4):904-12. PMC: 3055362. DOI: 10.1038/npp.2009.192. View

Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R . Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998; 11(6):266-72. DOI: 10.1002/(sici)1099-1492(199810)11:6<266::aid-nbm530>3.0.co;2-j. View

Friston K, Williams S, Howard R, Frackowiak R, Turner R . Movement-related effects in fMRI time-series. Magn Reson Med. 1996; 35(3):346-55. DOI: 10.1002/mrm.1910350312. View

Fan F, Tan S, Huang J, Chen S, Fan H, Wang Z . Functional disconnection between subsystems of the default mode network in schizophrenia. Psychol Med. 2020; 52(12):2270-2280. DOI: 10.1017/S003329172000416X. View

10.

Fritz M, MacKinnon D . Required sample size to detect the mediated effect. Psychol Sci. 2007; 18(3):233-9. PMC: 2843527. DOI: 10.1111/j.1467-9280.2007.01882.x. View

11.

Manoliu A, Riedl V, Zherdin A, Muhlau M, Schwerthoffer D, Scherr M . Aberrant dependence of default mode/central executive network interactions on anterior insular salience network activity in schizophrenia. Schizophr Bull. 2013; 40(2):428-37. PMC: 3932085. DOI: 10.1093/schbul/sbt037. View

12.

Kaminski J, Gleich T, Fukuda Y, Katthagen T, Gallinat J, Heinz A . Association of Cortical Glutamate and Working Memory Activation in Patients With Schizophrenia: A Multimodal Proton Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study. Biol Psychiatry. 2019; 87(3):225-233. DOI: 10.1016/j.biopsych.2019.07.011. View

13.

Gessa G, Devoto P, Diana M, Flore G, Melis M, Pistis M . Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology. 2000; 22(6):642-9. DOI: 10.1016/S0893-133X(00)00087-7. View

14.

Han W, Sorg C, Zheng C, Yang Q, Zhang X, Ternblom A . Low-rank network signatures in the triple network separate schizophrenia and major depressive disorder. Neuroimage Clin. 2019; 22:101725. PMC: 6389685. DOI: 10.1016/j.nicl.2019.101725. View

15.

Niessing J, Ebisch B, Schmidt K, Niessing M, Singer W, Galuske R . Hemodynamic signals correlate tightly with synchronized gamma oscillations. Science. 2005; 309(5736):948-51. DOI: 10.1126/science.1110948. View

16.

Marin O . Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012; 13(2):107-20. DOI: 10.1038/nrn3155. View

17.

Uhlhaas P, Singer W . Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010; 11(2):100-13. DOI: 10.1038/nrn2774. View

18.

Overbeek G, Gawne T, Reid M, Salibi N, Kraguljac N, White D . Relationship Between Cortical Excitation and Inhibition and Task-Induced Activation and Deactivation: A Combined Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study at 7T in First-Episode Psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 4(2):121-130. PMC: 7899089. DOI: 10.1016/j.bpsc.2018.10.002. View

19.

Menon V . Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci. 2011; 15(10):483-506. DOI: 10.1016/j.tics.2011.08.003. View

20.

Xi Z, Baker D, Shen H, Carson D, Kalivas P . Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J Pharmacol Exp Ther. 2001; 300(1):162-71. DOI: 10.1124/jpet.300.1.162. View